Escitalopram-induced Parkinsonism

General Hospital Psychiatry

Volumn 36, Issue 1, 2014, Pages 126.e1-126.e2

  Ak, Sertaç ^a   Yaǧcioǧlu, A Elif Anil ^b  

^a Aksaray State Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Biperiden; Escitalopram; Extrapyramidal side effects; Parkinsonism

Indexed keywords

AMFEBUTAMONE; BIPERIDEN; ESCITALOPRAM;

ADULT; ANGER; ARTICLE; BRADYKINESIA; BRAIN RADIOGRAPHY; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG SAFETY; DRUG WITHDRAWAL; DYSARTHRIA; FACIAL EXPRESSION; HUMAN; IMPULSE CONTROL DISORDER; MAINTENANCE THERAPY; MALE; MOTOR DYSFUNCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; RIGIDITY; SLOWNESS; TREMOR; WALKING DIFFICULTY;

BIPERIDEN; ESCITALOPRAM; EXTRAPYRAMIDAL SIDE EFFECTS; PARKINSONISM;

ADULT; ANTIPARKINSON AGENTS; BIPERIDEN; CITALOPRAM; HUMANS; IMPULSE CONTROL DISORDERS; MALE; PARKINSONIAN DISORDERS; SEROTONIN UPTAKE INHIBITORS;

EID: 85058721053     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.09.010     Document Type: Article

References (15)

1. Meltzer H.Y., Young M., Metz J., Fang V.S., Schyve P.M., Arora R.C. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm 1979, 45(2):165-175.
2. Madhusoodanan S., Alexeenko L., Sanders R., Brenner R. Extrapyramidal symptoms associated with antidepressants-a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry 2010, 22(3):148-156.
3. Gill H.S., DeVane C.L., Risch S.C. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol 1997, 17(5):377-389.
4. Schillevoort I., van Puijenbroek E.P., de Boer A., Roos R.A., Jansen P.A., Leufkens H.G. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case control study using spontaneous reports. Int Clin Psychopharmacol 2002, 17(2):75-79.
5. Lane R.M. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol 1998, 12(2):192-214.
6. American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM IV) 1994, American Psychiatric Association Press, Washington, DC.
7. Coulter D.M., Pillans P.I. Fluoxetine and extrapyramidal side effects. Am J Psychiatry 1995, 152:122-125.
8. Schrag A., Ben-Shlomo Y., Brown R., Marsden C.D., Quinn N. Young-onset Parkinson's disease revisited-clinical features, natural history, and mortality. Mov Disord 1998, 13(6):885-894.
9. Tsai C.H., Lo S.K., See L.C., Chen H.Z., Chen R.S., Weng Y.H., Chang F.C., Lu C.S. Environmental risk factors of young onset Parkinson's disease: a case-control study. Clin Neurol Neurosurg 2002, 104(4):328-333.
10. Brajkovic L.D., Svetel M.V., Kostic V.S., Sobic-Saranovic D.P., Pavlovic S.V., Artiko V.M., Obradovic V.B. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease. Hell J Nucl Med 2012, 15(2):134-138.
11. Elvan O., Soygur H., Cankurtaran E.S., Turhan L., Cekic T., Akarsu E.S., et al. Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report. Prog Neuro-Psychopharmacol Biol Psychiatry 2006, 30(7):1337-1339.
12. Taycan S.E., Demir S., Celikel F.C. The relationship of selective serotonin reuptake inhibitors with Parkinson's disease and Parkinsonism: two case reports. Anadolu Psikiyatri Derg 2011, 12(4):315-317.
13. MacGillivray L., Reynolds K.B., Sickand M., Rosebush P.I., Mazurek M.F. Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. Synapse 2011, 65(11):1166-1172.
14. Alvarez M.V., Evidente V.G. Understanding drug-induced parkinsonism: separating pearls from oy-sters. Neurology 2008, 70(8):e32-e34.
15. Miletić V., Relja M. Citalopram-induced Parkinsonian syndrome: case report. Clin Neuropharmacol 2011, 34(2):92-93.